(LHYFE) Lhyfe - Ratings and Ratios
Exchange: PA • Country: France • Currency: EUR • Type: Common Stock • ISIN: FR0014009YQ1
LHYFE: Renewable Energy, Green Hydrogen, Production Units
Lhyfe SA, a French renewable energy innovator, pioneers the development, installation, and operation of green hydrogen production facilities. Specializing in electrolysis technology, the company leverages renewable energy sources to produce zero-emission hydrogen, addressing the growing demand for decarbonized energy solutions. Lhyfe SA has established a robust portfolio of 93 projects across France, catering to a diverse range of sectors including local authorities, industrial complexes, transport networks, and fuel distribution hubs. Founded in 2017 and headquartered in Nantes, France, the company is at the forefront of the green hydrogen revolution, playing a critical role in the transition to sustainable energy systems.
From a technical perspective, Lhyfe SAs stock (Ticker: LHYFE) on the Paris Stock Exchange (PA) exhibits a 20-day average volume of 13,918 shares, with a last price of €3.42. The stocks moving averages indicate a recent price of €3.43 over 20 days, €3.27 over 50 days, and €3.60 over 200 days, suggesting a recent decline below the longer-term average. The Average True Range (ATR) of €0.14 reflects moderate volatility.
On the fundamental side, Lhyfe SA boasts a market capitalization of €163.40 million, with a price-to-book (P/B) ratio of 1.93, indicating that investors value the company slightly above its book value. However, the price-to-sales (P/S) ratio of 62.80 highlights a premium valuation relative to its revenue. The company currently reports a negative return on equity (RoE) of -54.71%, reflecting the early-stage nature of its operations and investments in growth.
Additional Sources for LHYFE Stock
LHYFE Stock Overview
Market Cap in USD | 169m |
Sector | Basic Materials |
Industry | Specialty Chemicals |
GiC Sub-Industry | Specialty Chemicals |
IPO / Inception |
LHYFE Stock Ratings
Growth Rating | -68.8 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | 4.55 |
Analysts | - |
Fair Price Momentum | 3.33 EUR |
Fair Price DCF | - |
LHYFE Dividends
No Dividends PaidLHYFE Growth Ratios
Growth Correlation 3m | -38.6% |
Growth Correlation 12m | -85.1% |
Growth Correlation 5y | -93.3% |
CAGR 5y | -22.36% |
CAGR/Max DD 5y | -0.30 |
Sharpe Ratio 12m | -0.08 |
Alpha | -7.24 |
Beta | 0.076 |
Volatility | 46.89% |
Current Volume | 158.4k |
Average Volume 20d | 15.3k |
As of April 19, 2025, the stock is trading at EUR 4.10 with a total of 158,393 shares traded.
Over the past week, the price has changed by +27.53%, over one month by +26.74%, over three months by +30.99% and over the past year by -3.30%.
No, based on ValueRay Analyses, Lhyfe (PA:LHYFE) is currently (April 2025) a stock to sell. It has a ValueRay Growth Rating of -68.81 and therefor a clear technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of LHYFE as of April 2025 is 3.33. This means that LHYFE is currently overvalued and has a potential downside of -18.78%.
Lhyfe has no consensus analysts rating.
According to ValueRays Forecast Model, LHYFE Lhyfe will be worth about 3.7 in April 2026. The stock is currently trading at 4.10. This means that the stock has a potential downside of -10.49%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 5.1 | 23.9% |
Analysts Target Price | - | - |
ValueRay Target Price | 3.7 | -10.5% |